• Join
  • Login
  • Contact

Search abstracts

Legislation and quality control of herbal medicinal products – Regulatory aspects on phytoequivalence, pharmaceutical equivalence and bioavailability.

  • At: 2009 FIP Congress in Istanbul (Turkey)
  • Type: Presentation
  • By: KNOESS, Werner (Federal Institute for Drugs and Medical Devices, Bonn, Germany)
  • Co-author(s): Reh, Klaus (Federal Institute for Drugs and Medical Devices, Bonn, Germany)
  • Abstract:

    The European Union has established a common regulatory framework for (traditional) herbal medicinal products. Definitions and basic principles are laid down in Directive 2001/83 and its amendments. Specific guidance has been developed by the Committee on Herbal Medicinal Products (HMPC) at the European Medicines Agency in London. Recent guidance


  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses